Cargando…
Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study)
INTRODUCTION: Little is known about the first line induction chemotherapy cycles for HIV-associated diffuse large B-cell lymphoma (DLBCL) as these are less common than HIV-negative lymphoma. Currently, the optimal treatment cycles option remains undefined. Therefore, we performed a multi-center stud...
Autores principales: | Wang, Chaoyu, Wu, Yan, Liu, Jun, Min, Haiyan, Huang, Yunhong, Wei, Guo, Zhang, Wei, Wang, Min, Tang, Xiaoqiong, Zhou, Hui, Chen, Yaokai, Liu, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090414/ https://www.ncbi.nlm.nih.gov/pubmed/37063928 http://dx.doi.org/10.3389/fimmu.2023.1153790 |
Ejemplares similares
-
PB2300: IMPACT OF INITIAL CHEMOTHERAPY CYCLES AND CLINICAL CHARACTERISTICS ON OUTCOMES FOR HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA PATIENTS: THE CENTRAL AND WESTERN CHINA AIDS LYMPHOMA LEAGUE STUDY
por: Wang, Chaoyu, et al.
Publicado: (2023) -
Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma
por: Sangha, Randeep, et al.
Publicado: (2022) -
First-Principles
Study on the Electronic and Mechanical
Properties of the Cr(001)/Al(001) Structure
por: Park, Soon-Dong, et al.
Publicado: (2023) -
JMR CHCO-001
Publicado: (2017) -
OP 001-035
Publicado: (2005)